Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The probiotic effects ascribed to lactic acid bacteria (LAB) and their fermented dairy products arise not only from whole microorganisms and cell wall components but also from peptides and extracellular polysaccharides (exopolysaccharides) produced during the fermentation of milk. There is a lack of knowledge concerning the immune mechanisms induced by exopolysaccharides produced by lactic acid bacteria, which would allow a better understanding of the functional effects described to them. The aim of this study was to investigate the in vivo immunomodulating capacity of the exopolysaccharide produced by Lactobacillus kefiranofaciens by analyzing the profile of cytokines and immunoglobulins induced at the intestinal mucosa level, in the intestinal fluid and blood serum. BALB/c mice received the exopolysaccharide produced by L. kefiranofaciens for 2, 5 or 7 consecutive days. At the end of each period of administration, control and treated mice were sacrificed and the numbers of IgA+ and IgG+ cells were determined on histological slices of the small and large intestine by immunofluorescence. Cytokines (IL-4, IL-6, IL-10, IL-12, IFNgamma and TNFalpha) were also determined in the gut lamina propria as well as in the intestinal fluid and blood serum. There was an increase of IgA+ cells in the small and large intestine lamina propria, without change in the number of IgG+ cells in the small intestine. This study reports the effects of the oral administration of the exopolysaccharide produced by L. kefiranofaciens in the number of IgA+ cells in the small and large intestine, comparing simultaneously the production of cytokines by cells of the lamina propria and in the intestinal fluid and blood serum. The increase in the number of IgA+ cells was not simultaneously accompanied by an enhance of the number of IL-4+ cells in the small intestine. This finding would be in accordance with the fact that, in general, polysaccharide antigens elicit a T-independent immune response. For IL-10+, IL-6+ and IL-12+ cells, the values found were slightly increased compared to control values, while IFNgamma+ and TNFalpha+ cells did not change compared to control values. The effects observed on immunoglobulins and in all the cytokines assayed in the large intestine after kefiran administration were of greater magnitude than the ones observed in the small intestine lamina propria, which may be due to the saccharolytic action of the colonic microflora. In the intestinal fluid, only IL-4 and IL-12 increased compared to control values. In blood serum, all the cytokines assayed followed a pattern of production quite similar to the one found for them in the small intestine lamina propria. We observed that the exopolysaccharide induced a gut mucosal response and it was able to up and down regulate it for protective immunity, maintaining intestinal homeostasis, enhancing the IgA production at both the small and large intestine level and influencing the systemic immunity through the cytokines released to the circulating blood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A PARAFFIN EMBEDDING TECHNIQUE FOR STUDIES EMPLOYING IMMUNOFLUORESCENCE
SAINTE-MARIE, G. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.250 · Cited by 1,108
Potential Uses of Probiotics in Clinical Practice
Reid, G., Jass, J., Sebulsky, M. T., & McCormick, J. K. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.658-672.2003 · Cited by 912
Fermented functional foods based on probiotics and their biogenic metabolites
Stanton, C., Ross, R. P., Fitzgerald, G. F., & Sinderen, D. V. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.02.008 · Cited by 496
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
Handbook of Fermented Functional Foods
(2003) · CRC Press eBooks · doi:10.1201/9780203009727 · Cited by 434
Antimicrobial and healing activity of kefir and kefiran extract
Rodrigues, K. L., Caputo, L. R. G., Carvalho, J. C. T., Evangelista, J., & Schneedorf, J. M. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.020 · Cited by 380
Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Mercenier, A., Pavan, S., & Pot, B. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392224 · Cited by 342
Polysaccharide processing and presentation by the MHCII pathway
Cobb, B. A., Wang, Q., Tzianabos, A. O., & Kasper, D. L. (2004) · Cell · doi:10.1016/j.cell.2004.05.001 · Cited by 340 · cited 1×
“However, it was recently reported that polysaccharides might also behave as T-dependent antigens [40].”
BackgroundImmunomodulating capacity of kefir
Vinderola, C. G., Duarte, J., Thangavel, D., Perdigón, G., Farnworth, E., & Matar, C. (2005) · Journal of Dairy Research · doi:10.1017/s0022029905000828 · Cited by 210
Self-citationSignaling in B cells via Toll-like receptors
Peng, S. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.03.003 · Cited by 209
Cited by
Genes and Molecules of Lactobacilli Supporting Probiotic Action
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-08 · Cited by 1,013
“kefiranofaciens ATCC 43761, consisting of equal amounts of glucose and galactose, induced a mucosal immune response in mice that included the induction of IgA-positive cells (264).”
BackgroundNew Perspectives for Lactobacilli Exopolysaccharides
Badel, S., Bernardi, T., & Michaud, P. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.08.011 · Cited by 497
The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
Bourrie, B. C. T., Willing, B. P., & Cotter, P. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00647 · Cited by 438
Caggianiello, G., Kleerebezem, M., & Spano, G. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7471-2 · Cited by 396
“Several health bene f i t s have been a t t r i bu t ed to the mic rob i a l exopolysaccharides, such as immune-st imulatory (Vinderola et al. 2006; Hidalgo-Cantabrana et al. 2012; Matsuzaki et al. 2014) and antitumoral effects (Kitazawa et al.”
BackgroundRahbar Saadat, Y., Yari Khosroushahi, A., & Pourghassem Gargari, B. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.04.025 · Cited by 370
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Sánchez-Alcoholado, L., Ramos-Molina, B., Otero, A., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez-Millán, J., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 337
Lynch, K. M., Zannini, E., Coffey, A., & Arendt, E. K. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012537 · Cited by 289
“Serum levels of interleukin 6 (IL-6), IL-4, IFN-γ, and IL-10 increased compared to those of controls, indicative of an immune response (Vinderola et al. 2006).”
BackgroundPotentials of Exopolysaccharides from Lactic Acid Bacteria
Patel, S., Majumder, A., & Goyal, A. (2012) · Indian Journal of Microbiology · doi:10.1007/s12088-011-0148-8 · Cited by 275
Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications
Krishna Rao, R., & Samak, G. (2013) · Current Nutrition & Food Science · doi:10.2174/1573401311309020004 · Cited by 266
The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits
Tsai, Y.-T., Cheng, P.-C., & Pan, T.-M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4407-3 · Cited by 260
Kefir and Its Biological Activities
Azizi, N. F., Kumar, M. R., Yeap, S. K., Abdullah, J. O., Khalid, M., Omar, A. R., Osman, M. A., Mortadza, S. A. S., & Alitheen, N. B. (2021) · Foods · doi:10.3390/foods10061210 · Cited by 256
Kefir and Health: A Contemporary Perspective
Ahmed, Z., Wang, Y., Ahmad, A., Khan, S. T., Nisa, M., Ahmad, H., & Afreen, A. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.540360 · Cited by 242
Antioxidant Activity of an Exopolysaccharide Purified from Lactococcus lactis subsp. lactis 12
Pan, D., & Mei, X. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.01.005 · Cited by 211
Jeong, D., Kim, D.-H., Kang, I.-B., Kim, H., Song, K.-Y., Kim, H.-S., & Seo, K.-H. (2017) · Food Control · doi:10.1016/j.foodcont.2017.02.033 · Cited by 198
Kefir micro-organisms: their role in grain assembly and health properties of fermented milk
Bengoa, A. A., Iraporda, C., Garrote, G. L., & Abraham, A. G. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14107 · Cited by 197
Xu, Y., Cui, Y., Yue, F., Liu, L., Shan, Y., Liu, B., Zhou, Y., & Lü, X. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.03.032 · Cited by 189
Drago, L. (2019) · Microorganisms · doi:10.3390/microorganisms7030066 · Cited by 171
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
“Health benefits associated with EPS include immunostimulatory effects((88,141)), blood cholesterol-lowering effects((87,142)) and prebiotic effects((143,144)).”
BackgroundSalva, S., Villena, J., & Alvarez, S. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.03.013 · Cited by 159
Stack, H. M., Kearney, N., Stanton, C., Fitzgerald, G. F., & Ross, R. P. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01524-09 · Cited by 145
“In addition to their use in food production, EPSs have been reported to possess a number of health benefits, such as immunostimulatory and antitumoral/anticarcinogenic effects (31, 69), lowering blood cholesterol (41, 46), and prebiotic effects (33, 44).”
BackgroundLactobacillus-produced exopolysaccharides and their potential health benefits: A review
Patten, D. A., & Laws, A. P. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0117 · Cited by 100
“EPS-producing starter cultures have long been used in traditional fermented drinks, such as Kefir (Vinderola et al., 2006) or the Scandinavian fermented milk drinks Viili (RuasMadiedo et al.”
BackgroundMatsuzaki, C., Hayakawa, A., Matsumoto, K., Katoh, T., Yamamoto, K., & Hisa, K. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b01960 · Cited by 89
KHOURY, N., EL-HAYEK, S., TARRAS, O., EL-SABBAN, M., EL-SIBAI, M., & RIZK, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2635 · Cited by 77
“Since then, many health benefits have been attributed to kefir, including its ability to stimulate the immune system (7), improve lactose digestion in lactose-intolerant individuals (8), decrease serum cholesterol levels (9), provide resistance against enteric and diarrheal diseases (10), act as an antifungal and anti…”
BackgroundAntiobesity Effect of Exopolysaccharides Isolated from Kefir Grains
Lim, J., Kale, M., Kim, D.-H., Kim, H.-S., Chon, J.-W., Seo, K.-H., Lee, H. G., Yokoyama, W., & Kim, H. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03764 · Cited by 70
Jeong, D., Kim, D.-H., Kang, I.-B., Kim, H., Song, K.-Y., Kim, H.-S., & Seo, K.-H. (2017) · Food & Function · doi:10.1039/c6fo01559j · Cited by 65
Bourrie, B. C. T., Cotter, P. D., & Willing, B. P. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.039 · Cited by 64
Topuz, E., Derin, D., Can, G., Kürklü, E., Çınar, S., Aykan, F., Çevikbaş, A., Dişçi, R., Durna, Z., Şakar, B., et al. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9171-y · Cited by 49
“[20] investigated the in vivo immunomodulating capacity of the kefiran by analyzing the profile of cytokines in the blood serum of mice.”
BackgroundO’Brien, K. V., Stewart, L. K., Forney, L. A., Aryana, K. J., Prinyawiwatkul, W., & Boeneke, C. A. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9392 · Cited by 46
Kefiran Protects Caco-2 Cells from Cytopathic Effects Induced by Bacillus cereus Infection
Medrano, M., Hamet, M. F., Abraham, A. G., & Pérez, P. F. (2009) · Antonie van Leeuwenhoek · doi:10.1007/s10482-009-9366-z · Cited by 46
Inhibitory effect of kefiran on ovalbumin-induced lung inflammation in a murine model of asthma
Kwon, O.-K., Ahn, K.-S., Lee, M.-Y., Kim, S.-Y., Park, B.-Y., Kim, M.-K., Lee, I.-Y., Oh, S.-R., & Lee, H.-K. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-2156-4 · Cited by 45
Khalil, E. S., Manap, M. Y., Mustafa, S., Amid, M., Alhelli, A. M., & Aljoubori, A. (2018) · CyTA - Journal of Food · doi:10.1080/19476337.2017.1401007 · Cited by 43
Lindström, C., Holst, O., Nilsson, L., Öste, R., & Andersson, K. E. (2012) · AMB Express · doi:10.1186/2191-0855-2-66 · Cited by 38
Domingos-Lopes, M. F. P., Nagy, A., Stanton, C., Ross, P. R., Gelencsér, E., & Silva, C. C. G. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.03.054 · Cited by 35
Dose-dependent effects of kefir on colitis induced by trinitrobenzene sulfonic acid in rats
Sevencan, N. O., Isler, M., Kapucuoglu, F. N., Senol, A., Kayhan, B., Kiztanir, S., & Kockar, M. C. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1174 · Cited by 22
Teruya, K., Myojin-Maekawa, Y., Shimamoto, F., Watanabe, H., Nakamichi, N., Tokumaru, K., Tokumaru, S., & Shirahata, S. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00709 · Cited by 15
Metadata
- Authors
- Vinderola, G., Perdigón, G., Duarte, J., Farnworth, E., & Matar, C.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 36
- Issue
- 5-6
- Pages
- 254-260
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W1988464004
- Cited by
- 291
- References
- 46
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.